Delaware Patient Informed Consent Form for Treatment
Delaware Patient Informed Consent Form for Treatment
I. Patient and Provider Identification
| Field | Entry |
|---|---|
| Patient Name | [____________________________________] |
| Date of Birth | [__/__/____] |
| Medical Record No. | [____________________________________] |
| Treating Provider | [____________________________________] |
| Provider License No. (DE) | [____________________________________] |
| Facility / Practice | [____________________________________] |
| Date of Consent Discussion | [__/__/____] |
| Time | [_____:_____ ☐ AM ☐ PM] |
II. Proposed Treatment, Procedure, or Diagnostic Service
Description of proposed care: [________________________________________________]
Anatomical site (if applicable): [____________________________________]
Anticipated date(s) of service: [__/__/____] through [__/__/____]
Provider performing the service: [____________________________________]
Anesthesia type (if any):
☐ None ☐ Local ☐ Regional ☐ Monitored anesthesia care ☐ General ☐ Other: [__________]
III. Statutory Disclosure (18 Del. C. § 6852)
I acknowledge that my provider has discussed the following with me to a degree reasonably comprehensible to general lay understanding:
☐ The nature of the proposed treatment, procedure, or diagnosis.
☐ The purpose and intended benefits of the proposed care.
☐ The material risks, including those a reasonable patient in my position would consider significant.
☐ The reasonable alternatives to the proposed care, including non-treatment.
☐ The probable consequences of declining the proposed care.
☐ My right to ask questions and to withdraw consent at any time before the procedure begins.
IV. Specific Risks Disclosed
The following specific risks were disclosed and discussed:
- [____________________________________]
- [____________________________________]
- [____________________________________]
- [____________________________________]
- [____________________________________]
Material risks may include (check all discussed):
☐ Bleeding ☐ Infection ☐ Adverse drug reaction ☐ Anesthesia complications
☐ Damage to adjacent structures ☐ Need for further procedures ☐ Scarring
☐ Loss of function ☐ Permanent disability ☐ Death (low probability)
☐ Other: [____________________________________]
V. Alternatives Considered
| Alternative | Discussed | Patient Election |
|---|---|---|
| Continue current management / observation | ☐ Yes ☐ No | ☐ Declined ☐ Elected |
| Medication-only therapy | ☐ Yes ☐ No | ☐ Declined ☐ Elected |
| Less invasive procedure | ☐ Yes ☐ No | ☐ Declined ☐ Elected |
| Referral to specialist | ☐ Yes ☐ No | ☐ Declined ☐ Elected |
| No treatment | ☐ Yes ☐ No | ☐ Declined ☐ Elected |
VI. Capacity Determination
☐ Patient is 18 years of age or older and appears to possess decision-making capacity.
☐ Patient is a minor; consent provided pursuant to 13 Del. C. § 707 by:
☐ Parent ☐ Legal guardian ☐ Relative caregiver (per § 707(b)) ☐ Married minor (self)
☐ Minor 18+ self-consenting ☐ Emancipated minor (court order attached)
☐ Patient lacks capacity; consent provided by health-care agent or surrogate pursuant to 16 Del. C. ch. 25:
☐ Agent under advance health-care directive ☐ Default surrogate per 16 Del. C. § 2507
☐ Court-appointed guardian (Order No. [__________])
VII. Minor-Specific Self-Consent (Where Applicable)
A minor may self-consent in Delaware for the following without parental involvement:
☐ Sexually transmitted disease examination/treatment — 16 Del. C. § 710 (any age).
☐ Pregnancy-related care — well-established under § 707 framework for minors.
☐ Voluntary substance-abuse treatment — 16 Del. C. § 2210:
☐ Minor under 14: parent/guardian consent required.
☐ Minor age 14+: minor may self-consent to non-residential treatment.
☐ Residential treatment: parent/guardian consent required regardless of age.
☐ Married minor or minor 18+ — full self-consent under 13 Del. C. § 707.
☐ Emancipated minor — by court order.
VIII. Emergency Exception
☐ This consent form is not required because emergency treatment is being rendered to a patient who is unable to consent and no surrogate is reasonably available; care is necessary to prevent serious harm or death (implied consent doctrine).
Documenting clinician: [____________________________________]
Time emergency began: [_____:_____ ☐ AM ☐ PM] on [__/__/____]
IX. Statutory Defenses Acknowledged
I understand and acknowledge:
☐ Hazards inherent in the proposed treatment that a person of ordinary intelligence in my position could reasonably appreciate.
☐ I am proceeding regardless of the disclosed risks and have had ample opportunity to ask questions.
☐ I waive no right to refuse, withdraw, or condition my consent.
X. Special Authorizations
☐ Photography / video / imaging for the medical record.
☐ Photography / video for educational or training purposes (de-identified).
☐ Tissue / specimen disposition in accordance with facility policy.
☐ Blood products administration, if medically indicated.
☐ Patient declines blood products: [____________________________________]
☐ Trainees / residents / students may participate under attending supervision.
☐ Implants / devices as medically indicated.
XI. Interpreter and Communication Aids
☐ Patient is fluent in English; no interpreter needed.
☐ Interpreter provided in [__________] language.
Interpreter Name: [____________________________] ID: [__________]
☐ Patient is hearing-impaired; ASL/CART services provided.
☐ Patient has cognitive limitations addressed by: [__________________________]
XII. Patient Acknowledgment and Signature
I have read or had read to me the contents of this form. My questions have been answered to my satisfaction. I voluntarily authorize the named provider and necessary assistants to perform the treatment described above.
| Signatory | Signature | Date |
|---|---|---|
| Patient | [_____________________] | [__/__/____] |
| Parent / Guardian / Surrogate | [_____________________] | [__/__/____] |
| Authority (relationship) | [_____________________] | [__/__/____] |
| Witness | [_____________________] | [__/__/____] |
XIII. Provider Attestation
I have personally discussed the proposed treatment with the patient (or authorized decision-maker), including the nature, purpose, material risks, reasonable alternatives, and probable consequences of refusal, in a manner consistent with the disclosure customarily given by Delaware-licensed providers in the same or similar field. I have answered all questions to the patient's apparent satisfaction.
| Provider | Signature | Date / Time |
|---|---|---|
| Treating Provider | [_____________________] | [__/__/____] [_____:_____] |
| DEA / License No. | [_____________________] |
XIV. Withdrawal of Consent
I understand consent may be withdrawn orally or in writing at any time before the procedure begins, and that withdrawal will not affect my right to alternative care.
Withdrawn on: [__/__/____] at [_____:_____ ☐ AM ☐ PM]
Patient signature: [____________________________________]
Witness: [____________________________________]
Sources and References
- 18 Del. C. § 6852 (Informed Consent in Medical Negligence Actions)
- 16 Del. C. ch. 25 (Uniform Health-Care Decisions Act)
- 13 Del. C. § 707 (Consent to Health Care of Minors)
- 16 Del. C. § 710 (Minor Consent — STDs)
- 16 Del. C. § 2210 (Substance Abuse — Voluntary Treatment Consent)
- Delaware Board of Medical Licensure and Discipline regulations, 24 DE Admin. Code 1700
About This Template
These templates cover the everyday paperwork that happens between patients, providers, and health plans: consent forms, medical record authorizations, directives for end-of-life care, and requests to approve or deny treatment. Getting them right matters because they document medical decisions, release sensitive health information, and often have to meet both federal privacy rules and state-specific requirements. A form that is missing a required disclosure can be rejected by a provider or challenged later in court.
Important Notice
This template is provided for informational purposes. It is not legal advice. We recommend having an attorney review any legal document before signing, especially for high-value or complex matters.
Last updated: May 2026